Tech Company Financing Transactions

Achaogen Funding Round

Arch Venture Partners invested in a $2.2 million funding round for Achaogen. The round was announced on 9/30/2010.

Transaction Overview

Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$2,232,000
Round
Undisclosed
Investors

Arch Venture Partners (Kristina Burow)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Tower Pl. 400
San Francisco, CA 94080
USA
Email Address
Overview
Achaogen is dedicated to addressing serious medical needs caused by the development of bacterial resistance to antibiotics.
Profile
Achaogen LinkedIn Company Profile
Social Media
Achaogen Company Twitter Account
Company News
Achaogen News
Facebook
Achaogen on Facebook
YouTube
Achaogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Blake Wise
  Blake Wise LinkedIn Profile  Blake Wise Twitter Account  Blake Wise News  Blake Wise on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2010: Nfocus Neuromedical venture capital transaction
Next: 9/30/2010: Active Endpoints venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary